Bedrijfstakpensioenfonds Voor DE Media PNO continued to hold its position in shares of Metlife Inc (NYSE:MET) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,300 shares of the financial services provider’s stock at the end of the first quarter. Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings in Metlife were worth $1,125,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently modified their holdings of MET. Sheaff Brock Investment Advisors LLC boosted its position in Metlife by 58.8% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 13,510 shares of the financial services provider’s stock valued at $714,000 after buying an additional 5,003 shares during the period. Daiwa Securities Group Inc. boosted its position in Metlife by 29.7% in the first quarter. Daiwa Securities Group Inc. now owns 190,301 shares of the financial services provider’s stock valued at $10,052,000 after buying an additional 43,621 shares during the period. Bbva Compass Bancshares Inc. boosted its position in Metlife by 2.7% in the first quarter. Bbva Compass Bancshares Inc. now owns 100,319 shares of the financial services provider’s stock valued at $5,299,000 after buying an additional 2,668 shares during the period. Canandaigua National Bank & Trust Co. bought a new position in Metlife during the first quarter valued at $1,018,000. Finally, Diamond Hill Capital Management Inc. boosted its position in Metlife by 16.1% in the first quarter. Diamond Hill Capital Management Inc. now owns 6,838,929 shares of the financial services provider’s stock valued at $361,232,000 after buying an additional 950,133 shares during the period. Hedge funds and other institutional investors own 74.92% of the company’s stock.
Shares of Metlife Inc (NYSE:MET) opened at 51.19 on Friday. The stock has a 50 day moving average of $51.69 and a 200-day moving average of $53.31. The firm’s market cap is $55.08 billion. Metlife Inc has a 52 week low of $36.17 and a 52 week high of $58.09. Metlife also saw unusually large options trading activity on Tuesday. Traders purchased 25,679 put options on the stock. This represents an increase of 361% compared to the average volume of 5,568 put options.
Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, May 3rd. The financial services provider reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.19. The company had revenue of $16.27 billion for the quarter, compared to analyst estimates of $17.02 billion. Metlife had a net margin of 1.30% and a return on equity of 7.17%. The business’s quarterly revenue was down 11.7% on a year-over-year basis. During the same period last year, the business posted $1.20 EPS. Equities research analysts expect that Metlife Inc will post $5.38 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 13th. Stockholders of record on Monday, May 8th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, May 4th. This represents a $1.60 annualized dividend and a dividend yield of 3.13%. Metlife’s dividend payout ratio (DPR) is currently 262.30%.
TRADEMARK VIOLATION WARNING: This report was first posted by BBNS and is the property of of BBNS. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://baseballnewssource.com/markets/bedrijfstakpensioenfonds-voor-de-media-pno-holds-stake-in-metlife-inc-met/849526.html.
MET has been the subject of several research analyst reports. TheStreet upgraded shares of Metlife from a “c” rating to a “b-” rating in a report on Monday, April 3rd. Royal Bank of Canada reiterated a “buy” rating and issued a $61.00 price target on shares of Metlife in a report on Monday, February 6th. Deutsche Bank AG reiterated a “buy” rating and issued a $65.00 price target on shares of Metlife in a report on Sunday, February 5th. Wells Fargo & Co reiterated a “buy” rating on shares of Metlife in a report on Monday, March 27th. Finally, Vetr cut shares of Metlife from a “strong-buy” rating to a “buy” rating and set a $55.49 price target for the company. in a report on Monday, March 27th. Four analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $55.94.
In other news, Director James M. Kilts purchased 2,795 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st. The stock was purchased at an average cost of $54.17 per share, with a total value of $151,405.15. Following the acquisition, the director now directly owns 41,951 shares of the company’s stock, valued at approximately $2,272,485.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director James M. Kilts purchased 17,205 shares of the business’s stock in a transaction that occurred on Wednesday, March 22nd. The shares were purchased at an average cost of $51.13 per share, with a total value of $879,691.65. Following the completion of the acquisition, the director now directly owns 59,443 shares in the company, valued at $3,039,320.59. The disclosure for this purchase can be found here. 0.27% of the stock is currently owned by insiders.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife Inc and related companies with our FREE daily email newsletter.